Q1 EPS Estimate for Zevra Therapeutics Raised by Analyst
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Free Report) – Equities research analysts at Roth Capital boosted their Q1 2025 earnings per share (EPS) estimates for Zevra Therapeutics in a research note issued on Tuesday, March 11th. Roth Capital analyst J. Aschoff now expects that the company will earn ($0.17) per share for the quarter, up from […]
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Free Report) – Equities research analysts at Roth Capital boosted their Q1 2025 earnings per share (EPS) estimates for Zevra Therapeutics in a research note issued on Tuesday, March 11th. Roth Capital analyst J. Aschoff now expects that the company will earn ($0.17) per share for the quarter, up from […]
